Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 10 patients with ...

Or, MD, a distinguished researcher and neurologist at Penn Medicine, is the winner of the 2025 John Dystel Prize for Multiple ...

The AdventHealth Neuroscience Institute is testing IDP-023 for primary or nonactive secondary progressive multiple sclerosis ...

A new study has found that eating fish could help to slow the progression of multiple sclerosis (MS). We look at the research ...

Columnist Ahna Crum spent years trying to go it alone. Now she knows that freedom comes when she's flocking together with ...

The American Association for the Advancement of Science recognized Yale researchers for their contributions to medicine, ...

A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link ...

When futurists of the past envisioned 21st-century healthcare, it often came with some loss of humanity. The ...

Researchers from institutions across France have uncovered solid clinical evidence that supplements of vitamin D could be an ...

Clene (NASDAQ: CLNN) , a late clinical-stage biopharmaceutical company advancing treatments for neurodegenerative diseases like ALS and MS, will pres ...

Brain Bank Singapore collects human brain tissue after a donor’s death and preserves it for use in research that aims to help ...

(Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called ...